Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2019 and Highlights Recent Corporate Progress

Thursday, May 9, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

HERON THERAPEUTICS, INC.Condensed Consolidated Balance Sheet Data(in thousands)

March 31,

December 31,

2019

2018

(unaudited)

Cash, cash equivalents and short-term investments

$       289,238

$        332,371

Accounts receivable, net

74,007

64,652

Total assets

435,794

462,179

Total stockholders' equity

331,814

370,160



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store